Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Receivables (2016 - 2026)

Amphastar Pharmaceuticals has reported Change in Receivables over the past 13 years, most recently at -$3.2 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 11.22% year-over-year to -$3.2 million; the TTM value through Dec 2025 reached $6.4 million, down 70.62%, while the annual FY2025 figure was $6.4 million, 70.62% down from the prior year.
  • Change in Receivables for Q4 2025 was -$3.2 million at Amphastar Pharmaceuticals, down from $13.8 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $23.2 million in Q1 2024 and troughed at -$12.3 million in Q2 2025.
  • A 5-year average of $4.0 million and a median of $4.3 million in 2021 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: soared 1430.46% in 2022 and later plummeted 428.82% in 2024.
  • Year by year, Change in Receivables stood at $755000.0 in 2021, then soared by 1430.46% to $11.6 million in 2022, then plummeted by 135.39% to -$4.1 million in 2023, then rose by 28.93% to -$2.9 million in 2024, then decreased by 11.22% to -$3.2 million in 2025.
  • Business Quant data shows Change in Receivables for AMPH at -$3.2 million in Q4 2025, $13.8 million in Q3 2025, and -$12.3 million in Q2 2025.